Levosimendan : Studies on its mechanisms of action and beyond [PDF]
, 2009 Acute heart failure syndrome represents a prominent and growing health problem all around the world. Ideally, medical treatment for patients admitted to hospital because of this syndrome, in addition to alleviating the acute symptoms, should also prevent
Kaheinen, Petri
core
Levosimendan in Right Ventricular Dysfunction. [PDF]
Ann Card Anaesth, 2023 Kapoor MC.
europepmc +1 more source
Adrenergic Shock Presenting with Atypical Takotsubo Syndrome: The Alliance Between Levosimendan and Intraaortic Balloon Pump Against the Pheochromocytoma. [PDF]
Anatol J Cardiol, 2022 Vincenza Polito M +5 more
europepmc +1 more source
Leveraging innovation to mitigate risk during heart surgery [PDF]
, 2023 Kachroo, Puja, Moon, Marc R
core +2 more sources
, 2008 Uutta tietoa typpioksidista, tulehduksesta ja tulehduslääkkeistä Typpioksidi on elimistön signaalimolekyyli, joka säätelee mm. immunologista puolustusjärjestelmää. Tulehdussairauksissa, kuten astmassa, reumassa, nivelrikossa ja septisessä sokissa, typpioksidin tuotanto on lisääntynyt.
openaire +1 more source
LEVOSIMENDAN'S ABILITY ON VENO-ARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION WEANING: EVIDENCE SAYS YES! [PDF]
, 2023 Alberto Marabotti +4 more
core +1 more source
Medikamentöse Therapie der akuten Herzinsuffizienz [PDF]
, 2019 Zusammenfassung: Hintergrund: Die Therapie der akuten Herzinsuffizienz besteht in der schnellstmöglichen Beseitigung der Lungen- und/oder systemischen Stauung. Eine gezielte Diagnostik und ein schneller Therapiebeginn sind wichtig.
Herrmann, T. +2 more
core
The anti-inflammatory and haemodynamic effects of levosimendan on advanced heart failure patients: a meta-analysis of published studies. [PDF]
J Int Med Res, 2023 Zhou S, Li D, Zhang L, Li J.
europepmc +1 more source
Effect of intravenous levosimendan or milrinone on left atrial pressure in patients undergoing off-pump coronary artery bypass grafting-A prospective double-blind, randomized controlled trial. [PDF]
Ann Card Anaesth, 2023 Mondal A +4 more
europepmc +1 more source
Use of levosimendan in patient with heart failure with reduced ejection fraction, clinical case [PDF]
Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, Chişinău, Republica MoldovaIntroducere. O strategie utilizată în managementul insuficienței cardiace cu fracție de ejecție redusă (IC-FEr) este creșterea contractilității miocardice ...
Cernous,Alexandr +4 more
core